Immunotherapy for pancreatic cancer boosts survival more than 75 percent in  mice, study finds

Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

4.6
(428)
Write Review
More
$ 31.99
Add to Cart
In stock
Description

Microorganisms, Free Full-Text

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy - ScienceDirect

Hutch News Fred Hutchinson Cancer Center

Crafting a better T cell for immunotherapy

Hutch News Fred Hutchinson Cancer Center

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Frontiers Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer

media.springer/full/springer-static/imag

Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds

Biomedicines, Free Full-Text

Experimental study design and treatments. Sixty male C57BL/6 mice were

Mielcarek study may change the practice of blood stem-cell transplantation

Crafting a better T cell for immunotherapy

Cancers, Free Full-Text

Hutch News Fred Hutchinson Cancer Center